Clinical Trial Update: Intrathecal Chemoprophylaxis to Prevent Neurotoxicity Associated With Blinatumomab Therapy for Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating intrathecal chemoprophylaxis to prevent neurotoxicity from blinatumomab in patients with acute lymphoblastic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• BLINCYTO (BLINATUMOMAB)

Snippet

Sponsor: Northside Hospital, Inc. | Conditions: Acute Lymphoblastic Leukemia | Phase 2 | Status: RECRUITING